Synergy between CD52 and CD20 Antibody-Induced Apoptosis Correlates with the Extent of Co-Expression of CD20 and CD52 Antigens on Mononuclear Cells Derived from Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin’s Lymphoma (NHL) Patients: Implications to Antibody-Based Therapy.